title: Alopecia universalis treated with bone morphogenetic protein?
authors.forename: K S
authors.initials: KS
authors.lastname: Leslie
authors.forename: S N
authors.initials: SN
authors.lastname: Shah
authors.forename: C
authors.initials: C
authors.lastname: Darrah
authors.forename: A
authors.initials: A
authors.lastname: Cooper
authors.forename: A
authors.initials: A
authors.lastname: Valentin-Opran
authors.forename: A D
authors.initials: AD
authors.lastname: Patel
authors.forename: S T
authors.initials: ST
authors.lastname: Donel
mesh_terms: D000328:Adult; D000505:Alopecia / Q000188:drug therapy*; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D006801:Humans; D033162:Incidental Findings; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D013978:Tibial Fractures / Q000188:drug therapy; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*
chemical_list: C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta